CN112062836B - 猪塞尼卡谷病毒高效价阳性血清及其制备方法 - Google Patents
猪塞尼卡谷病毒高效价阳性血清及其制备方法 Download PDFInfo
- Publication number
- CN112062836B CN112062836B CN202010898616.0A CN202010898616A CN112062836B CN 112062836 B CN112062836 B CN 112062836B CN 202010898616 A CN202010898616 A CN 202010898616A CN 112062836 B CN112062836 B CN 112062836B
- Authority
- CN
- China
- Prior art keywords
- virus
- valley virus
- seneca valley
- porcine
- immunization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000002966 serum Anatomy 0.000 title claims abstract description 81
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- 241000837158 Senecavirus A Species 0.000 title claims description 77
- 239000000427 antigen Substances 0.000 claims abstract description 59
- 102000036639 antigens Human genes 0.000 claims abstract description 59
- 108091007433 antigens Proteins 0.000 claims abstract description 59
- 241000700605 Viruses Species 0.000 claims abstract description 57
- 229940031551 inactivated vaccine Drugs 0.000 claims abstract description 34
- 239000007788 liquid Substances 0.000 claims abstract description 33
- 238000000034 method Methods 0.000 claims abstract description 21
- 241000700198 Cavia Species 0.000 claims abstract description 15
- 230000003053 immunization Effects 0.000 claims description 77
- 238000002649 immunization Methods 0.000 claims description 72
- 239000000243 solution Substances 0.000 claims description 46
- 241000282898 Sus scrofa Species 0.000 claims description 30
- 241000700199 Cavia porcellus Species 0.000 claims description 26
- 239000002671 adjuvant Substances 0.000 claims description 26
- 230000003472 neutralizing effect Effects 0.000 claims description 16
- 239000012071 phase Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 230000002779 inactivation Effects 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 230000036039 immunity Effects 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 claims description 8
- 235000019345 sodium thiosulphate Nutrition 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 7
- 239000008280 blood Substances 0.000 claims description 7
- 239000002480 mineral oil Substances 0.000 claims description 7
- 235000010446 mineral oil Nutrition 0.000 claims description 7
- 230000000415 inactivating effect Effects 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 6
- 239000007924 injection Substances 0.000 claims description 6
- 210000003205 muscle Anatomy 0.000 claims description 6
- 230000001804 emulsifying effect Effects 0.000 claims description 5
- 238000004114 suspension culture Methods 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 239000008346 aqueous phase Substances 0.000 claims description 3
- 238000012360 testing method Methods 0.000 abstract description 19
- 238000006386 neutralization reaction Methods 0.000 abstract description 15
- 238000010171 animal model Methods 0.000 abstract description 10
- 229960005486 vaccine Drugs 0.000 abstract description 7
- 230000002195 synergetic effect Effects 0.000 abstract description 5
- 238000003745 diagnosis Methods 0.000 abstract description 4
- 230000008105 immune reaction Effects 0.000 abstract description 4
- 238000013095 identification testing Methods 0.000 abstract description 3
- 230000004936 stimulating effect Effects 0.000 abstract description 3
- 238000003756 stirring Methods 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 10
- 239000000725 suspension Substances 0.000 description 9
- 238000010257 thawing Methods 0.000 description 9
- 241000283973 Oryctolagus cuniculus Species 0.000 description 8
- 239000012530 fluid Substances 0.000 description 7
- 230000003833 cell viability Effects 0.000 description 6
- 238000007710 freezing Methods 0.000 description 6
- 230000008014 freezing Effects 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 238000012258 culturing Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 4
- 238000004945 emulsification Methods 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 230000002163 immunogen Effects 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- 241000282887 Suidae Species 0.000 description 3
- 230000000120 cytopathologic effect Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 241000701386 African swine fever virus Species 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 2
- 241001673669 Porcine circovirus 2 Species 0.000 description 2
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000002051 biphasic effect Effects 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 101710179738 6,7-dimethyl-8-ribityllumazine synthase 1 Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 101710186608 Lipoyl synthase 1 Proteins 0.000 description 1
- 101710137584 Lipoyl synthase 1, chloroplastic Proteins 0.000 description 1
- 101710090391 Lipoyl synthase 1, mitochondrial Proteins 0.000 description 1
- 241000709664 Picornaviridae Species 0.000 description 1
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 1
- 231100000645 Reed–Muench method Toxicity 0.000 description 1
- 241000531781 Rhynochetidae Species 0.000 description 1
- 241001632234 Senecavirus Species 0.000 description 1
- 238000004115 adherent culture Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 244000037640 animal pathogen Species 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 210000000003 hoof Anatomy 0.000 description 1
- 230000000521 hyperimmunizing effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036046 immunoreaction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 208000009305 pseudorabies Diseases 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1009—Picornaviridae, e.g. hepatitis A virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/35—Valency
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32051—Methods of production or purification of viral material
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010898616.0A CN112062836B (zh) | 2020-08-31 | 2020-08-31 | 猪塞尼卡谷病毒高效价阳性血清及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010898616.0A CN112062836B (zh) | 2020-08-31 | 2020-08-31 | 猪塞尼卡谷病毒高效价阳性血清及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112062836A CN112062836A (zh) | 2020-12-11 |
CN112062836B true CN112062836B (zh) | 2022-07-29 |
Family
ID=73665894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010898616.0A Active CN112062836B (zh) | 2020-08-31 | 2020-08-31 | 猪塞尼卡谷病毒高效价阳性血清及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112062836B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113252891A (zh) * | 2021-01-08 | 2021-08-13 | 中国农业科学院兰州兽医研究所 | 检测塞尼卡病毒a抗体的试剂盒 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105548536A (zh) * | 2015-12-08 | 2016-05-04 | 天津瑞普生物技术股份有限公司 | 一种猪乙型脑炎病毒抗体阳性血清的制备方法 |
CN105732807A (zh) * | 2016-02-24 | 2016-07-06 | 福州大北农生物技术有限公司 | 一种猪伪狂犬病病毒阳性血清的制备方法 |
CN106632671A (zh) * | 2017-01-11 | 2017-05-10 | 福州大北农生物技术有限公司 | 一种猪传染性胃肠炎病毒阳性血清的制备方法 |
CN106699881A (zh) * | 2017-01-11 | 2017-05-24 | 福州大北农生物技术有限公司 | 一种猪流行性腹泻病毒阳性血清的制备方法 |
CN108103078A (zh) * | 2018-01-03 | 2018-06-01 | 中国农业科学院兰州兽医研究所 | 塞尼卡谷病毒疫苗及其制备方法和应用 |
CN109490529A (zh) * | 2018-11-20 | 2019-03-19 | 金宇保灵生物药品有限公司 | 塞内卡病毒的阻断elisa抗体检测试剂盒 |
CN109554352A (zh) * | 2018-11-20 | 2019-04-02 | 中牧实业股份有限公司 | 塞尼卡谷病毒svv-zm-201801及其应用 |
CN109627330A (zh) * | 2018-12-18 | 2019-04-16 | 马鞍山史记动物健康管理有限公司 | 一种猪伪狂犬病毒高效价阳性血清制备方法 |
CN109679927A (zh) * | 2019-02-25 | 2019-04-26 | 中国农业科学院兰州兽医研究所 | 猪塞内加谷病毒、猪塞内加谷病毒灭活疫苗的制备方法、猪塞内加谷病毒灭活疫苗和应用 |
CN110157659A (zh) * | 2019-05-28 | 2019-08-23 | 中牧实业股份有限公司 | 一种bhk-21细胞系bhk-21-bp-2克隆株及其在全悬浮细胞培养中的应用 |
-
2020
- 2020-08-31 CN CN202010898616.0A patent/CN112062836B/zh active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105548536A (zh) * | 2015-12-08 | 2016-05-04 | 天津瑞普生物技术股份有限公司 | 一种猪乙型脑炎病毒抗体阳性血清的制备方法 |
CN105732807A (zh) * | 2016-02-24 | 2016-07-06 | 福州大北农生物技术有限公司 | 一种猪伪狂犬病病毒阳性血清的制备方法 |
CN106632671A (zh) * | 2017-01-11 | 2017-05-10 | 福州大北农生物技术有限公司 | 一种猪传染性胃肠炎病毒阳性血清的制备方法 |
CN106699881A (zh) * | 2017-01-11 | 2017-05-24 | 福州大北农生物技术有限公司 | 一种猪流行性腹泻病毒阳性血清的制备方法 |
CN108103078A (zh) * | 2018-01-03 | 2018-06-01 | 中国农业科学院兰州兽医研究所 | 塞尼卡谷病毒疫苗及其制备方法和应用 |
CN109490529A (zh) * | 2018-11-20 | 2019-03-19 | 金宇保灵生物药品有限公司 | 塞内卡病毒的阻断elisa抗体检测试剂盒 |
CN109554352A (zh) * | 2018-11-20 | 2019-04-02 | 中牧实业股份有限公司 | 塞尼卡谷病毒svv-zm-201801及其应用 |
CN109627330A (zh) * | 2018-12-18 | 2019-04-16 | 马鞍山史记动物健康管理有限公司 | 一种猪伪狂犬病毒高效价阳性血清制备方法 |
CN109679927A (zh) * | 2019-02-25 | 2019-04-26 | 中国农业科学院兰州兽医研究所 | 猪塞内加谷病毒、猪塞内加谷病毒灭活疫苗的制备方法、猪塞内加谷病毒灭活疫苗和应用 |
CN110157659A (zh) * | 2019-05-28 | 2019-08-23 | 中牧实业股份有限公司 | 一种bhk-21细胞系bhk-21-bp-2克隆株及其在全悬浮细胞培养中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN112062836A (zh) | 2020-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110251671B (zh) | 鹅星状病毒卵黄抗原抗体复合物制备方法 | |
CN1940063A (zh) | 一种伪狂犬病gEˉ/gIˉ基因缺失毒株、含有该毒株的灭活疫苗及应用 | |
CN105963692B (zh) | 一种预防手足口病的联合疫苗 | |
CN113388587B (zh) | 表达牛病毒性腹泻e2基因的重组牛结节疹病毒及其应用 | |
CN111500482B (zh) | 一种羊a型产气荚膜梭菌菌株及其灭活疫苗和疫苗制备方法 | |
CN111041002A (zh) | 猪流行性腹泻病毒变异株2a、2b二价灭活疫苗及其制备方法 | |
CN104258386B (zh) | 一种水貂病毒性肠炎灭活疫苗-犬瘟热活疫苗组合 | |
CN112062836B (zh) | 猪塞尼卡谷病毒高效价阳性血清及其制备方法 | |
CN112717128B (zh) | 一种预防手足口病的联合疫苗及其制备方法和应用 | |
CN108465107B (zh) | 一种鸭2型腺病毒和番鸭细小病毒病二联灭活疫苗 | |
CN112195161B (zh) | 一种犬细小病毒疫苗株、疫苗及其制备方法 | |
CN109954135A (zh) | 牛a型产气荚膜梭菌灭活类毒素疫苗及其制备方法 | |
CN112341539A (zh) | 防治具有跨种传播能力的新型鹅星状病毒的卵黄抗体及其制备方法 | |
CN112063596A (zh) | 鸽副黏病毒1型ppmv-1/bj-c株及其应用 | |
CN116121202B (zh) | 一种柯萨奇病毒b组1型毒株及应用 | |
CN111686246B (zh) | 一种用于猪流行性腹泻病毒的抗原抗体复合物疫苗及其制备方法 | |
CN102600469A (zh) | 一种猪瘟活疫苗 | |
CN111000995A (zh) | 猪用三联灭活疫苗及其制备方法和应用 | |
CN110974949A (zh) | 猪用二联灭活疫苗及其制备方法和应用 | |
CN116615234A (zh) | 一种预防手足口病的联合疫苗及其制备方法和应用 | |
CN111110839A (zh) | 一种预防雏鹅痛风的鹅星状病毒二价灭活疫苗 | |
CN112522217B (zh) | 一种犬瘟热弱毒株及其制备的疫苗组合物和应用 | |
CN110950950B (zh) | 一种大熊猫犬瘟热病毒的异源抗体及其制备方法 | |
CN117100849B (zh) | 一种赤羽病毒阳性血清及其制备方法 | |
CN115786276B (zh) | 牦牛轮状病毒分离株及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Wu Shanshan Inventor after: Sun Yao Inventor after: Wang Guihua Inventor after: Zhang Henan Inventor after: Yang Junjing Inventor after: Han Wei Inventor before: Wu Shanshan Inventor before: Wang Guihua Inventor before: Zhang Henan Inventor before: Yang Junjing Inventor before: Han Wei |
|
CB03 | Change of inventor or designer information |